Patents Examined by Christopher Tate
  • Patent number: 7198807
    Abstract: Compositions for the treatment of acne have an active ingredient in an amount sufficient to inhibit the growth of Propionibacterium acnes and, optionally, at least one inactive ingredient, where the active ingredient is selected from the group consisting of green tea extract, grape seed extract, cranberry extract, and mixtures thereof. The compositions may be substantially free of skin-irritating materials.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: April 3, 2007
    Assignee: Triarco Industries, Inc.
    Inventors: Mark L. Anderson, Andres Menendez, Rodger E. Bogardus
  • Patent number: 7195789
    Abstract: A composition comprising a non-fiber organic extract of psyllium which is anti-tumorigenic is described. The composition both restores gap junctional intercellular communication (GJIC) and inhibits anchorage independent growth of mammalian cells which have been transformed with the ras oncogene. The composition is a useful chemotherapy and chemopreventative agent. The composition was identified using a novel method for determining the anti-tumorigenic potential of a compound or composition.
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: March 27, 2007
    Assignee: Board of Trustees of Michigan State University
    Inventors: Yasushi Nakamura, Brad L. Upham, James E. Trosko
  • Patent number: 7195790
    Abstract: Extracts from plants in the Asteridae subfamily, such as Carthamus tinctorious, are effective to selectively inhibit COX-2 activity and/or enhance COX-1 activity. When Asteridae extracts are combined with boswellic acid, the combination exhibits a synergistic inhibitory effect on both COX-2 and LO. Such extracts and combinations are used in methods of selectively inhibiting COX-2, inhibiting LO, and/or enhancing COX-1 activity as well as in the methods of treating conditions that would respond favorably to any of these effects.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: March 27, 2007
    Assignee: Shaklee Corporation
    Inventors: Peter X. Zhang, Michael T. Yatcilla
  • Patent number: 7192613
    Abstract: The invention concerns Allium sativum bulb absolutes, compositions containing them, and uses thereof for therapeutic purposes—in particular in the treatment of obesity—and for cosmetic purposes—in particular for the treatment of the skin, of cellulite and of localized dermal adipose deposits.
    Type: Grant
    Filed: October 22, 2002
    Date of Patent: March 20, 2007
    Assignee: Pierre Fabre Dermo-Cosmetique
    Inventor: Isabelle Tomatis
  • Patent number: 7189420
    Abstract: This invention provides a composition comprising extracts from the husk of Wenguanguo and a process of producing the combined extract comprising the following steps: extracting Wenguanguo husks with an organic solvent to form an organic extract; removing the organic solvent from the extract to form aqueous extracts; and drying and sterilizing the aqueous extracts to form the combined extracts. The extracts can be used to make medicines or health foods for preventing cerebral aging, improving memory, improving cerebral functions and curing enuresis, frequent micturition, urinary incontinence, dementia, weak intelligence and Alzheimer's disease and other diseases caused by cerebral dysfunction. The combined extracts contain saponin, saccharides, proteins and others.
    Type: Grant
    Filed: August 28, 2002
    Date of Patent: March 13, 2007
    Assignee: Fountain Silver Limited
    Inventor: Yun Wang
  • Patent number: 7182963
    Abstract: The invention relates to the use of an extract of olive leaves (Olea europaea) which is titrated in oleanolic acid and which may or may not be associated with a Larrea divaricata extract which is titrated in nordihydroguaiaretic acid (NDGA). Said products are intended for all types of cosmetic and dermopharmaceutical compositions for all forms of skin care, for moisturizing and anti-inflammatory purposes and, in particular, for the prevention and treatment of skin prone to acne.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: February 27, 2007
    Assignee: Sederma
    Inventor: Karl Lintner
  • Patent number: 7179469
    Abstract: The use of a food portion comprising dry and/or wet distiller's grain for preventing, treating or ameliorating cardiovascular pathologies is described.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: February 20, 2007
    Inventor: Rajat Sethi
  • Patent number: 7172771
    Abstract: The present invention relates to methods for preparing red ginseng and puffed snack enriched with red ginseng, from raw ginseng or white ginseng, using an extrusion process. The red ginseng and red ginseng powder prepared according to the present invention can be produced at larger amounts within a shorter time period than those of the conventional method for preparing red ginseng. In addition, since the red ginseng and red ginseng powder of the present invention need not to be subjected to an additional powdering step, they may be directly used as a raw material of secondary processed red ginseng products. Furthermore, as the directly puffed snack and indirectly puffed pellet prepared according to the method of present invention contain a high concentration of red ginseng, they may be used for light meals and cocktail appetizers while providing a health promotion effect.
    Type: Grant
    Filed: July 21, 2004
    Date of Patent: February 6, 2007
    Inventor: Gi-Hyung Ryu
  • Patent number: 7166307
    Abstract: The present invention relates to a Galla Rhois-containing composition to be spread on sanitary napkin for female. Preferably, the present invention further comprises one or more herb medicine selected from a group consisting of Artemisia Folia, Sophorae, flavescens, Phellodendri Cortex, Torilis anthriscus and alum.
    Type: Grant
    Filed: May 15, 2000
    Date of Patent: January 23, 2007
    Assignee: Deuk Hun AHN et al.
    Inventors: Deuk Hun Ahn, In Jin Baek, Tae Hun Ahn
  • Patent number: 7160562
    Abstract: The invention describes compositions and methods containing nonconventional plant materials, and more particularly the species Flemingia macrophylla and Careya arborea, that help to maintain normal blood sugar levels in humans and animals. The method of preparation of such compositions and methods of quantifying active principles therein are also described. A Metformin-like compound were found to be the active hypoglycemic principle in Flemingia macrophylla and Careya arborea root bark. The compositions of the invention were found to be safe for therapeutic use.
    Type: Grant
    Filed: May 25, 2004
    Date of Patent: January 9, 2007
    Assignee: Sami Labs Limited
    Inventors: Muhammed Majeed, Subbalakshmi Prakash, Shipra Roy, Venu Agarwal
  • Patent number: 7157083
    Abstract: The present invention relates to hyaluronidase enzyme methods, vaccines and compositions for treating or preventing pathogenic infections, such as HIV, in a patient. The invention also relates to methods, vaccines and compositions for providing immunity against HIV infection in a patient comprising treating the patient with HIV virus or HIV infected cells that have been treated with hyaluronidase.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: January 2, 2007
    Assignee: Surrogate Pharmaceutical Pathways, LLC
    Inventor: Damian J. Gallina
  • Patent number: 7157107
    Abstract: The present invention relates to a process for producing eggs with low cholesterol level. Different concentrations of fermented red mold rice are added to hens feeds. The fermented red mold rice contains Monacolin K, which has an effect on reducing cholesterol level. The cholesterol level in eggs produced by the present process is much lower than that in eggs produced by the prior art process. Furthermore, the serum triglyceride of hens is reduced. People are paying more attention to health, thus lowering consumption of high cholesterol food. Since cholesterol in eggs accounts for more than 50% of daily take-up, consumption of egg can hardly increase. Therefore, low cholesterol eggs can not only be beneficial to the public's health, but also bears business advantage.
    Type: Grant
    Filed: January 14, 2004
    Date of Patent: January 2, 2007
    Inventors: Tzu-Ming Pan, Chih-Chieh Wang
  • Patent number: 7147876
    Abstract: A medicinal or cosmetic composition comprising Aloe vera in combination with at least one vitamin, a minerals concentrate, an organic oils concentrate, at least one Chinese Herb, at least one essential oil and at least one spice. The composition may be administered orally or topically.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: December 12, 2006
    Inventors: Michael Hargreaves Riley, Jane Clarissa Fletcher
  • Patent number: 7125555
    Abstract: An oral preparation for reduction of mammalian, e.g. human, cat or dog, plaque and/or calculus, such as bacterial plaque, arteriosclerotic plaque, atherosclerotic plaque, pleural plaque, dental calculus, renal calculus, biliary calculus, and prostatic calculus, contains a Ascophyllum sp., especially A. nodosum, seaweed or an extract thereof. The oral preperation is suitable for use in prophylactic and/or therapeutic method of treating plaque and/or calculus in a mammalian individual.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: October 24, 2006
    Assignee: SDC SweDenCare AB
    Inventor: Sune Wikner
  • Patent number: 7115574
    Abstract: The invention includes a composition and method of treatment of sinusitis. A preferred embodiment of the invention is a composition for treatment of sinusitis comprising a therapeutically effective amount of one or more peptides selected from the group of peptides with a C-terminal sequence consisting of KPV (SEQ ID NO:1), HFRWGKPV (SEQ ID NO:2), and SYSMEHFRWGKPV (SEQ ID NO:3) used in combination with a therapeutically effective amount of an antihistamine/decongestant, corticosteroid, fungicide and/or antibiotic. In yet another embodiment of the invention, one or one or more peptides selected from the group of peptides with a C-terminal sequence consisting of KPV (SEQ ID NO:1), HFRWGKPV (SEQ ID NO:2), and SYSMEHFRWGKPV (SEQ ID NO:3), which may or may not be in combination with therapeutically effective amounts of antibiotics, corticosteroids and/or antihistamine/decongestants, are topically or systemically applied to treat sinusitis.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: October 3, 2006
    Assignee: Zengen, Inc.
    Inventors: Anna P Catania, James M Lipton
  • Patent number: 7115286
    Abstract: The present disclosure concerns methods and compositions to inhibit insects from biting a subject. In preferred embodiments, the compositions may be administered orally, for example using a spray bottle to deliver to the mouth. In certain embodiments, the compositions and methods are effective to reduce swelling, itching, redness and/or inflammation of the local area of an insect bite. The compositions may include one or more herbs selected from the group consisting of rice bran, peppermint, barley grass, lobelia; chlorella, watercress, alfalfa and parsley and one or more vitamins selected from the group consisting of thiamin (B-1), riboflavin (B-2), niacin (B-3), pantothenic acid (B-5), pyridoxine (B-6), folic acid (B-9), cyanocobalamin (B-12), choline, inositol, d-biotin, para-aminobenzoic acid, and lecithin. Administration of effective amounts of the compositions is sufficient to inhibit insects from biting and/or treat insect affected areas of a subject.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: October 3, 2006
    Inventor: Sarah Meredith
  • Patent number: 7115285
    Abstract: A composition for suppressing appetite and cravings for substances such as nicotine, coffee, sweets or chocolate while improving energy and enhancing mood comprises theobromine or a salt thereof at an effective amount of from about 250 to 4000 mg. Using such relatively high proportions of theobromine, without added caffeine or ephedrine provides an effective method for promoting weight control or to halt substance cravings without the side effects associated with such stimulants. The composition also includes Rhodiola rosea extract to offset stress effects from reduced food or substance intake, and to further improve mood, and clarity of thought and ability to handle stress, and to also increase endurance while reducing muscle pain.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: October 3, 2006
    Assignee: Eurark, LLC
    Inventors: Dwight McKee, Timothy A. Nolan
  • Patent number: 7101982
    Abstract: The invention provides methods of controlling pH variations during chromatography. In particular embodiments, the invention includes equilibrating and eluting proteins from chromatography resins have a solid phase that possesses a charged functional group on its backbone under controlled conditions of osmolarity and pH. The invention is particularly useful in the purification of proteins that are sensitive to pH transitions such as, for example, the IL-1 Receptor type II protein.
    Type: Grant
    Filed: March 29, 2002
    Date of Patent: September 5, 2006
    Assignee: Immunex Corporation
    Inventors: Sanchayita Ghose, Thomas M. McNerney
  • Patent number: 7097997
    Abstract: The invention relates to a method for diagnosing a transmissible spongiform subacute encephalopathy (TSSE) caused by an unconventional transmissible agent (UTA) or prion. The method involves treating a sample suspected of containing a prion with proteinase K for a time and under conditions that completely degrade normal prion protein (Prp-sen), but which only partially digest abnormal prion protein (PrP-res) so that all or some of the octapeptide motif repeats comprising P(H/Q)GGG(-/T)WGQ (SEQ ID NO: 1) in the abnormal prion protein (Prp-res) are retained.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: August 29, 2006
    Assignee: Commissariat a l'Energie Atomique
    Inventors: Jean-Philippe Deslys, Emmanuel Comoy, Jacques Grassi
  • Patent number: 7053044
    Abstract: SP-C analogue artificial peptides having surface activity are disclosed and their use for preparing artificial surfactants useful in the treatment of respiratory distress syndrome (RDS) and other diseases related to surfactant deficiency or dysfunction.
    Type: Grant
    Filed: February 9, 2000
    Date of Patent: May 30, 2006
    Assignee: Chiesi Farmaceutici S.p.A.
    Inventors: Tore Curstedt, Jan Johansson, Hans Jörnvall, Paolo Ventura